We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ARX market cap is 171.79M. The company's latest EPS is NZD -0.0012 and P/E is -416.67.
Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
Total Revenue | 23.32M | 25.08M | 22.34M | 39.68M | 63.36M |
Operating Income | 876k | -1.84M | -9.98M | -7.64M | -3.11M |
Net Income | 960k | -5.96M | -19.21M | -8.39M | -396k |
Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
Total Assets | 39.46M | 45.96M | 79.66M | 112.65M | 116.52M |
Total Liabilities | 27.46M | 38.36M | 21.17M | 12.16M | 14.63M |
Total Equity | 12M | 7.61M | 58.49M | 100.49M | 101.89M |
Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
Operating | -7k | 1.66M | -5.01M | -11.52M | -3.77M |
Investing | -3.71M | -1.87M | -21.5M | -34.87M | 7.26M |
Financing | 4.14M | -384k | 37.1M | 37.63M | -504k |
Market Cap | 171.79M |
Price to Earnings Ratio | -416.67 |
Price to Sales Ratio | 2.71 |
Price to Cash Ratio | 3.85 |
Price to Book Ratio | 1.69 |
Dividend Yield | - |
Shares Outstanding | 343.57M |
Average Volume (1 week) | 210.89k |
Average Volume (1 Month) | 177.43k |
52 Week Change | -52.83% |
52 Week High | 1.09 |
52 Week Low | 0.475 |
Spread (Intraday) | 0.02 (3.96%) |
Company Name | Aroa Biosurgery Limited |
Address |
2 kingsford smith place auckland 2022 |
Website | https://aroabio.com |
Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions